GHK-Cu is one of the best-known peptides in biochemical and dermatological research, with a literature that goes back more than 50 years. This overview explains what GHK-Cu is, how it was discovered, and what published studies have reported, with citations so researchers can go straight to the source.
What is GHK-Cu?
GHK is a tripeptide, a chain of three amino acids: glycine–histidine–lysine (glycyl-L-histidyl-L-lysine). It has a strong affinity for copper(II) ions. When bound to copper, the complex is called GHK-Cu, or copper tripeptide-1.
The copper-binding chemistry is central to how the molecule is studied. The histidine side chain and the peptide backbone coordinate the copper ion, forming a stable complex that researchers use to investigate copper transport and copper-dependent processes. A 2026 review in Pharmaceutics covers its coordination chemistry, formulation science and use as a delivery cargo in detail (Mateescu et al., 2026).
For research, GHK-Cu is typically supplied as a blue lyophilized powder. Its color comes from the copper complex.
Discovery
GHK was first isolated from human plasma in 1973 by Loren Pickart. Early observations noted that plasma levels of GHK differ with age, which led to decades of work on its biological activity in cell and tissue models. Pickart and colleagues have since published many reviews on the peptide (Pickart, J Biomater Sci Polym Ed, 2008).
What has the research examined?
Gene-expression data
Some of the most cited recent work on GHK uses gene-expression databases such as the Broad Institute’s Connectivity Map. Analyzing these datasets, Pickart and Margolina (2018) reported that GHK is associated with changes in the expression of a large number of human genes in cell-based data, including genes linked to tissue remodeling, antioxidant responses and the ubiquitin-proteasome system (Pickart & Margolina, Int J Mol Sci, 2018).
It is important to note that these findings come from computational analysis of in vitro expression profiles. They describe associations in cell lines, not outcomes in organisms.
Skin and extracellular matrix models
GHK-Cu has been widely studied in skin cell and tissue-remodeling models. A 2015 review in BioMed Research International summarized studies on fibroblast activity, collagen and glycosaminoglycan synthesis, and matrix metalloproteinase regulation in experimental systems (Pickart et al., 2015). The same review discussed the many cellular pathways that GHK appears to modulate in these models.
Oxidative stress models
Researchers have also looked at GHK-Cu in the context of oxidative stress. A 2012 paper in Oxidative Medicine and Cellular Longevity reviewed experimental evidence on GHK-Cu, antioxidant enzyme activity and the binding of reactive carbonyl species (Pickart et al., 2012).
Recent systematic reviews
The literature continues to grow. A 2026 systematic review assessed proposed mechanisms of GHK-Cu across published studies (Najafi et al., 2026). The authors also pointed out the variation in study design and the need for more standardized, well-controlled research.
Proposed mechanisms
Several mechanisms have been proposed from in vitro and animal data:
- Copper delivery. GHK may act as a carrier that moves bioavailable copper into cells.
- Gene-expression modulation. This is suggested by the Connectivity Map analyses.
- Matrix remodeling signals. These include effects on collagen synthesis and metalloproteinase activity in cell models.
- Antioxidant-related activity. This was observed in experimental oxidative-stress systems.
These remain areas of active investigation rather than settled conclusions.
Limitations of the current evidence
- Concentrated authorship. Much of the foundational review literature comes from a small number of authors.
- Model-dependent findings. Gene-expression results come from cell-line databases, and tissue results mostly from in vitro or animal models.
- Methodological variation. Studies differ in concentrations, formulations and endpoints, which makes them hard to compare directly.
- Not an approved drug. GHK-Cu as sold for research is a laboratory material. It is not an approved therapeutic in the US or Canada.
Related copper peptides
Researchers interested in GHK-Cu often study related copper-binding peptides as well. One example is AHK-Cu (alanine–histidine–lysine copper), which is used in comparative studies of copper peptide chemistry. Core Source Peptides also supplies AHK-Cu for this purpose.
Sourcing GHK-Cu for research
Quality matters even more with metal complexes. Researchers should look for:
- HPLC-verified purity (≥99% is a common benchmark)
- Consistent copper complexation, which shows as a uniform blue lyophilized cake
- Sealed, clearly labeled vials with batch tracking
- Cool, dry, dark storage, since copper complexes can be sensitive to light and moisture
Core Source Peptides supplies GHK-Cu 100mg at ≥99% purity (HPLC verified), shipped to the US and Canada.
Key takeaways
- GHK-Cu is the copper(II) complex of the tripeptide glycine–histidine–lysine, first isolated from human plasma in 1973.
- Research spans gene-expression analysis, skin and matrix models, and oxidative stress models.
- Most evidence is in vitro or preclinical, and much of the review literature comes from a few authors.
- Interest in its coordination chemistry and formulation is growing.
References
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018. https://pubmed.ncbi.nlm.nih.gov/29986520/
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015. https://pubmed.ncbi.nlm.nih.gov/26236730/
- Pickart L, et al. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging. Oxid Med Cell Longev. 2012. https://pubmed.ncbi.nlm.nih.gov/22666519/
- Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008. https://pubmed.ncbi.nlm.nih.gov/18644225/
- Mateescu DM, et al. GHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo. Pharmaceutics. 2026. https://pubmed.ncbi.nlm.nih.gov/42797253/
- Najafi N, et al. A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu. Arch Intern Med Res. 2026. https://pubmed.ncbi.nlm.nih.gov/42787770/
Disclaimer: All products sold by Core Source Peptides are intended strictly for laboratory research use only. They are not for human or veterinary use, are not drugs, foods or cosmetics, and are not intended to diagnose, treat, cure or prevent any disease. This article summarizes published scientific literature for educational purposes only and is not medical advice. Purchasers must be 21+ and qualified to handle research materials.